Amphastar Pharma (AMPH) Stock Price, Quote, News & History

Comments

Amphastar Pharmaceuticals Inc (AMPH) Stock Price, Quote, News & History

AMPHNASDAQ

Trade with Public

$20.37

-0.50-2.40%

At close: Apr 10, 5:00 PM EST

$20.37

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Options Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$20.98

Close

$20.37

Volume / Avg.

354.46K / 491.49K

Day Range

$20.14 - $21.10

52 Wk Range

17.03 - 31.26

Market Cap

$936.05M

P/E Ratio

10.28

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

16.54%

Days to Cover

5.15

Recent Amphastar Pharmaceuticals, Inc News

Top 2 Health Care Stocks That May Rocket Higher This Month

Avi Kapoor

JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability

JP Morgan assesses the specialty pharma sector, highlighting robust fundamentals and new product excitement. Key focus on Teva, Organon, and Viatris.

Vandana Singh

Eli Lilly Divests Low Blood Sugar Drug Baqsimi To Amphastar For $500M Cash

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

156.12M

Investing Cash Flow (TTM)

-70.33M

Financing Cash Flow (TTM)

-67.43M

Free Cash Flow (TTM)

118.98M

Capital Expenditure (TTM)

-37.13M

Net Change in Cash (TTM)

18.36M

Analyst Trends and Forecast

1

Oct 25

1

Nov 25

1

Dec 25

2

Feb

1

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.32B

PE Ratio (TTM)

10.28

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.40

PB Ratio (TTM)

1.20

Earnings Yield % (TTM)

9.73%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

6.22

Price / EBITDA (TTM)

4.74

Price / Free Cash Flow (TTM)

8.46

Book Value / Share

$17.39

Company Debt

Total Debt

$610.39M

LT Debt

$608.75M

LT Debt Issuance (TTM)

$6.22M

LT Debt Repayment (TTM)

-$223.00K

Total Cash

$170.18M

Debt to Equity

0.83

Issuance of Debt (TTM)

$5.99M

Repayment of Debt (TTM)

-$223.00K

Key Statistics

Open

$20.98

Close

$20.37

Volume / Avg.

354.46K / 491.49K

Day Range

$20.14 - $21.10

52 Wk Range

17.03 - 31.26

Market Cap

$936.05M

P/E Ratio

10.28

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

16.54%

Days to Cover

5.15

About

Sector

Health Care

Industry

Pharmaceuticals

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pha...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry

FAQ

Q

How do I buy Amphastar Pharma (AMPH) stock?

A

You can purchase shares of Amphastar Pharma (NASDAQ:AMPH) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Amphastar Pharma (AMPH) competitors?

A

Other companies in Amphastar Pharma’s space includes: Theravance Biopharma Inc (NASDAQ:TBPH), GH Research PLC (NASDAQ:GHRS), AtaiBeckley Inc (NASDAQ:ATAI), Bioage Labs Inc (NASDAQ:BIOA) and WAVE Life Sciences Ltd (NASDAQ:WVE).

Q

What is the forecast, or price target, for Amphastar Pharma (AMPH) stock?

A

Amphastar Pharma has a consensus price target of $37.40.

Q

What is the current price for Amphastar Pharma (AMPH)?

A

The stock price for Amphastar Pharma (NASDAQ: AMPH) is $20.37 last updated April 10, 2026 at 4:00 PM EDT.

Q

Does Amphastar Pharma (AMPH) pay a dividend?

A

There are no upcoming dividends for Amphastar Pharma.

Q

When is Amphastar Pharma (NASDAQ:AMPH) reporting earnings?

A

Amphastar Pharma does not have any upcoming earnings scheduled.

Q

Is Amphastar Pharma (AMPH) going to split?

A

There is no upcoming split for Amphastar Pharma.

Q

What sector and industry does Amphastar Pharma (AMPH) operate in?

A

Amphastar Pharma is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch

Theravance Biopharma Inc

WAVE Life Sciences Ltd

NASDAQ:WVE

$7.19

0.14%

Xeris Biopharma Holdings Inc

NASDAQ:XERS

$5.85

%

Phathom Pharmaceuticals Inc

Key Statistics

Open

$20.98

Close

$20.37

Volume / Avg.

354.46K / 491.49K

Day Range

$20.14 - $21.10

52 Wk Range

17.03 - 31.26

Market Cap

$936.05M

P/E Ratio

10.28

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

16.54%

Days to Cover

5.15

Recent Amphastar Pharmaceuticals, Inc News

Top 2 Health Care Stocks That May Rocket Higher This Month

Avi Kapoor

JP Morgan Shows Most Interest In Teva, Organon As Specialty Pharma Sector Exhibits Signs Of Stability

JP Morgan assesses the specialty pharma sector, highlighting robust fundamentals and new product excitement. Key focus on Teva, Organon, and Viatris.

Vandana Singh

Eli Lilly Divests Low Blood Sugar Drug Baqsimi To Amphastar For $500M Cash

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

156.12M

Investing Cash Flow (TTM)

-70.33M

Financing Cash Flow (TTM)

-67.43M

Free Cash Flow (TTM)

118.98M

Capital Expenditure (TTM)

-37.13M

Net Change in Cash (TTM)

18.36M

Analyst Trends and Forecast

1

Oct 25

1

Nov 25

1

Dec 25

2

Feb

1

Apr

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.0

Hold

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.32B

PE Ratio (TTM)

10.28

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.40

PB Ratio (TTM)

1.20

Earnings Yield % (TTM)

9.73%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

6.22

Price / EBITDA (TTM)

4.74

Price / Free Cash Flow (TTM)

8.46

Book Value / Share

$17.39

Company Debt

Total Debt

$610.39M

LT Debt

$608.75M

LT Debt Issuance (TTM)

$6.22M

LT Debt Repayment (TTM)

-$223.00K

Total Cash

$170.18M

Debt to Equity

0.83

Issuance of Debt (TTM)

$5.99M

Repayment of Debt (TTM)

-$223.00K

Key Statistics

Open

$20.98

Close

$20.37

Volume / Avg.

354.46K / 491.49K

Day Range

$20.14 - $21.10

52 Wk Range

17.03 - 31.26

Market Cap

$936.05M

P/E Ratio

10.28

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

16.54%

Days to Cover

5.15

About

Sector

Health Care

Industry

Pharmaceuticals

Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pha...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS better than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS better than industry